Getting from Genes to Function in Lung Disease A National Heart, Lung, and Blood Institute Workshop Report

Department of Human Genetics, The University of Chicago, Chicago, Illinois, USA.
American Journal of Respiratory and Critical Care Medicine (Impact Factor: 11.99). 09/2010; 182(6):732-7. DOI: 10.1164/rccm.201002-0180PP
Source: PubMed

ABSTRACT Genome-wide association studies (GWAS) have revealed novel genes and pathways involved in lung disease, many of which are potential targets for therapy. However, despite numerous successes, a large proportion of the genetic variance in disease risk remains unexplained, and the function of the associated genetic variations identified by GWAS and the mechanisms by which they alter individual risk for disease or pathogenesis are still largely unknown. The National Heart, Lung, and Blood Institute (NHLBI) convened a 2-day workshop to address these shortcomings and to make recommendations for future research areas that will move the scientific community beyond gene discovery. Topics of individual sessions ranged from data integration and systems genetics to functional validation of genetic variations in humans and model systems. There was broad consensus among the participants for five high-priority areas for future research, including the following: (1) integrated approaches to characterize the function of genetic variations, (2) studies on the role of environment and mechanisms of transcriptional and post-transcriptional regulation, (3) development of model systems to study gene function in complex biological systems, (4) comparative phenomic studies across lung diseases, and (5) training in and applications of bioinformatic approaches for comprehensive mining of existing data sets. Last, it was agreed that future research on lung diseases should integrate approaches across "-omic" technologies and to include ethnically/racially diverse populations in human studies of lung disease whenever possible.

Download full-text


Available from: Weiniu Gan, Jul 21, 2015
  • Source
    • "Table 2, adapted from reference Weiss et al. (2009), presents a list of candidate genes that have been associated with the asthma phenotype in at least three studies of sample sizes greater than a total of 300 subjects (150 cases and 150 controls). In October 2010, the Human Genetic Epidemiology Navigator database (HuGE Navigator, Yu et al., 2008) listed 674 and 519 genes reported to be associated with asthma and COPD, respectively, and their related traits. However, as discussed above, there has been a major problem in the replication of many of these findings. "
    [Show abstract] [Hide abstract]
    ABSTRACT: There has been a huge influx of data on the genetics and genomics of respiratory diseases in the last few years. Powered by large sample sizes from collaborations worldwide, recent genome-wide association studies have convincingly implicated variants in different regions in the genome for association with complex respiratory traits. These new associations have the potential to offer invaluable insight into the pathophysiology of the normal and diseased respiratory system. The functional mechanisms underlying effects of both identified and novel variants will be the focus of research over the next few years. The identification of these mechanisms will not only increase our understanding of disease but may allow the development of new therapies to alleviate respiratory conditions. The implications of these approaches for studies of asthma and Chronic Obstructive Pulmonary Disease are covered in this review.
    British Journal of Pharmacology 05/2011; 163(1):96-105. DOI:10.1111/j.1476-5381.2011.01222.x · 4.99 Impact Factor
  • Source
    American Journal of Respiratory and Critical Care Medicine 06/2011; 183(12):1614-9. DOI:10.1164/rccm.201103-0467UP · 11.99 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Asthma and allergy are common conditions with complex etiologies involving both genetic and environmental contributions. Recent genome-wide association studies (GWAS) and meta-analyses of GWAS have begun to shed light on both common and distinct pathways that contribute to asthma and allergic diseases. Associations with variation in genes encoding the epithelial cell-derived cytokines, interleukin-33 (IL-33) and thymic stromal lymphopoietin (TSLP), and the IL1RL1 gene encoding the IL-33 receptor, ST2, highlight the central roles for innate immune response pathways that promote the activation and differentiation of T-helper 2 cells in the pathogenesis of both asthma and allergic diseases. In contrast, variation at the 17q21 asthma locus, encoding the ORMDL3 and GSDML genes, is specifically associated with risk for childhood onset asthma. These and other genetic findings are providing a list of well-validated asthma and allergy susceptibility genes that are expanding our understanding of the common and unique biological pathways that are dysregulated in these related conditions. Ongoing studies will continue to broaden our understanding of asthma and allergy and unravel the mechanisms for the development of these complex traits.
    Immunological Reviews 07/2011; 242(1):10-30. DOI:10.1111/j.1600-065X.2011.01029.x · 12.91 Impact Factor
Show more